Key result
Current methods of heart valve allograft preservation, including cryopreservation, result in loss of cellular viability and structural integrity, highlighting the need for improved techniques to maintain valve growth capacity in children.
Why the study?
Current valve replacements do not provide a viable valve capable of growing or adapting with a child, leading to re-operation throughout life.
Improving donor heart valve preservation techniques is essential to maintain cellular viability and growth potential, which could prevent the need for repeated re-operations in pediatric patients.
Standard cryopreservation may hasten pediatric allograft failure; leaves open vitrification or antifreeze proteins for prospective trials.
Valvular heart disease affects 30% of the new-borns with congenital heart disease. Valve replacement of semilunar valves by mechanical, bioprosthetic or donor allograft valves is the main treatment approach. However, none of the replacements provides a viable valve that can grow and/or adapt with the growth of the child leading to re-operation throughout life. In this study, we review the impact of donor valve preservation on moving towards a more viable valve alternative for valve replacements in children or young adults.
No takes yet. Share an insight, caveat, or question.
Peters et al. (2023) conducted a review in Valvular heart disease in children (congenital heart disease). Heart valve preservation techniques (e.g., cryopreservation) was evaluated. Current methods of heart valve allograft preservation, including cryopreservation, result in loss of cellular viability and structural integrity, highlighting the need for improved techniques to maintain valve growth capacity in children.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: